Observational studyBMC musculoskeletal disorders2015

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.

Hubert G Nüßlein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.